Kiang-Teck Jerry Yeo, Ph.D. DABCC, FACB

Director, Clinical Chemistry Laboratories
Director, Clinical Pharmacogenomics &
Clinical Translational Mass Spectrometry Laboratories

Department of Pathology
The University of Chicago
5841 S. Maryland Avenue
MC 0004, Room TW-010
Chicago, IL 60637
Phone: 773.702.1318
Fax: 773.702.6268

Clinical Interests

Dr Jerry Yeo is a board-certified clinical chemist and toxicological chemist with broad expertise in clinical chemistry, therapeutic drug monitoring, toxicology, endocrinology testing, clinical pharmacogenetics and clinical proteomics.

Research Interests

Research focuses on blood biomarkers of cardiac diseases. These include cardiac troponin, BNP and NT-proBNP, and other new emerging biomarkers in cardiology.  Our laboratory is involved in Pharmacogenomics research, involving the genotyping various Cytochrome P450, transporters and other relevant polymorphisms using microarrays and next-gen sequencing methodologies.  In addition a new initiative is underway to develop and validate relevant protein and small molecule biomarkers employing high-resolution mass spectrometry methods for clinical research and implementation.  The ultimate goal is to translate these discoveries to foster personalized medicine in clinical practice.

Textbook Publications

  • Beisswenger PJ, Szwergold BS, Yeo K-T. Glycated Proteins in Diabetes. In: Goldstein BJ, Gorstein F, eds, Clinics in Laboratory Medicine: Diabetes Mellitus. Philadelphia : W.B. Saunders Co, 2001; pp53-78.
  • Yeo KT, Quinn-Hall KS, Bateman SW, Fischer GA, Wieczorek S, Wu AHB. Functional sensitivity of cardiac troponin assays and its implications for risk stratification for patients with acute coronary syndromes. In: Adams III JE, Apple FS, Jaffe AS , Wu AHB, eds. Markers in Cardiology:Current and Future Clinical Application. Armonk , NY :Futura Publ Co. Inc., 2001; pp. 23-30.
  • Yeo K-T, Hoefner DM. Interferences in Immunoassays of Cardiac Troponins. In: Wu AHB, ed, Cardiac Markers. Humana Press, 2003; pp187-197.
  • Yeo KTJ, Lee HK, Flanagan J. Therapeutic Drug Monitoring and Clinical Toxicology Chapter. In: Wu AHB, ed, Tietz Clinical Guide to Laboratory Tests, W.B. Saunders, 2006; 4th edition.
  • Wu AHB and Yeo, KTJ. Co-Editor of a textbook on Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory. Humana Press 2011; 1st edition.
  • Yeo KTJ, Babic N., Wu A.H.B. Issues in Translation of Pharmacogenomics into Clinical Practice. In: Wu AHB and Yeo KTJ, eds, Pharmacogenomic Testing in Current Clinical Practice. Humana Press 2011;pp 3-14
  • Babic N., Joseph LJ, Yeo KTJ. Molecular Diagnostic Methods in Pharmacogenomics. In: Wu AHB and Yeo KTJ, eds, Pharmacogenomic Testing in Current Clinical Practice. Humana Press 2011;pp 15-34
  • Wong SHY, Happy C, Blinka D, Gock S, Jentzen JM, Donald Hon. JM, Coleman H, Jortani SA, Lucire Y, Morris-Kukoski CL, Neuman MG, Orsulak PJ, Sander T, Wagner MA, Wynn JR, Wu AHB, Yeo KTJ. From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System. In: Wu AHB and Yeo KTJ, eds, Pharmacogenomic Testing in Current Clinical Practice. Humana Press 2011;pp 47-58

PubMed Link to Dr. K-T Yeo publications